Investment opportunity

We are looking for funding in order to move forward with our next clinical trial. Read more below.

Why to invest in Medicortex Finland Oy?

Medicortex is introducing in Finland a new diagnostic method for huge need of brain injury and concussion detection.

- Large customer potential and variable clients.

- Current company valuation ca. 6.5 M€.

- Exit planned as listing* on First North at Nasdaq Helsinki as soon as the valuation is above 10 M€.

- Four people team keeping the costs low, slim and lean organization.

* Pending BOD approval.

Investments will be used for the clinical trial and product development.

- Basic development done including preclinical and proof-of-concept human testing.

- Patent applications and PCT filed.

- Exciting Company, won twice an innovation prize.


Go back to Investors page